Canada - English - Health Canada

octapharma pharmazeutika produktionsges m b h - simoctocog alfa; water - kit - 2000unit; 2.5ml - simoctocog alfa 2000unit; water 2.5ml - hemostatics

Canada - English - Health Canada

octapharma pharmazeutika produktionsges m b h - simoctocog alfa; water - kit - 3000unit; 2.5ml - simoctocog alfa 3000unit; water 2.5ml - hemostatics

Canada - English - Health Canada

octapharma pharmazeutika produktionsges m b h - simoctocog alfa; water - kit - 4000unit; 2.5ml - simoctocog alfa 4000unit; water 2.5ml - hemostatics

Canada - English - Health Canada

octapharma pharmazeutika produktionsges m b h - simoctocog alfa; water - kit - 2500unit; 2.5ml - simoctocog alfa 2500unit; water 2.5ml - hemostatics

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pharmaniaga marketing sdn bhd - simoctocog alfa -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pharmaniaga marketing sdn bhd - simoctocog alfa -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pharmaniaga marketing sdn bhd - simoctocog alfa -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pharmaniaga marketing sdn bhd - simoctocog alfa -

Canada - English - Health Canada

octapharma pharmazeutika produktionsges m b h - simoctocog alfa; water - kit - 1500unit; 2.5ml - simoctocog alfa 1500unit; water 2.5ml

New Zealand - English - Medsafe (Medicines Safety Authority)

octapharma new zealand ltd - simoctocog alfa 1000 [iu] - powder for injection - 1000 iu - active: simoctocog alfa 1000 [iu] excipient: arginine hydrochloride calcium chloride dihydrate poloxamer 188 sodium chloride sodium citrate dihydrate sucrose water for injection - treatment and prophylaxis of bleeding (also during and after surgery) in previously treated paediatric (greater than or equal to 2 years) and adult patients with haemophilia a (congenital factor viii deficiency). nuwiq does not contain von willebrand factor and is thus not indicated to treat von willebrand's disease.